TY - JOUR
T1 - Independent predictors of secondary invasive pancreatic remnant tumors after initial resection of an intraductal papillary mucinous neoplasm
T2 - a nationwide large-scale survey in Japan
AU - Takigawa, Yutaka
AU - Kitago, Minoru
AU - Matsui, Junichi
N1 - Funding Information:
We thank all of the JSPS surgeons at the 91 principal institutes, who kindly participated in the study (Appendix 1). We also thank the support staff of the institutions that aided the work of the JSPS. We are grateful to Dr. Masateru Uchiyama, M.D., Ph.D., Mr. Kento Kawai, MSc, and Dr. Masanori Niimi, M.D., Ph.D., for their editorial assistance.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12
Y1 - 2020/12
N2 - Purpose: There is no standardized surveillance protocol after intraductal papillary mucinous neoplasm (IPMN) resection. We report the findings of a large-scale survey in Japan, investigating the independent predictors of secondary invasive tumors by analyzing the epidemiology of secondary tumors of the remnant pancreas after initial IPMN resection. Methods: An institutional questionnaire about the remnant pancreas after pancreas resection was distributed at the 41st Annual Meeting of the Japanese Society of Pancreatic Surgery in Tokyo. We retrospectively analyzed the patient data including pathological diagnosis, postoperative outcomes, and evaluation methods. Results: Redo pancreatectomy was performed for secondary disease in 213 (1.4%) of a total 15,777 patients. Eighty-eight of these 213 patients had undergone initial resection of IPMN. The types of secondary tumors after IPMN resection significantly depended on those of the primary tumors. Through short-interval and long-term follow-up, most of the secondary tumors were detected within 1–4 years. Logistic regression analysis revealed that the initial pathological diagnosis of invasive IPMN was an independent predictor of secondary invasive tumors in the remnant pancreas. Conclusion: Primary invasive IPMN proved to be a significant predictor of secondary invasive IPMN. Both short-interval and long-term follow-up may help to determine the prognosis of patients after IPMN resection.
AB - Purpose: There is no standardized surveillance protocol after intraductal papillary mucinous neoplasm (IPMN) resection. We report the findings of a large-scale survey in Japan, investigating the independent predictors of secondary invasive tumors by analyzing the epidemiology of secondary tumors of the remnant pancreas after initial IPMN resection. Methods: An institutional questionnaire about the remnant pancreas after pancreas resection was distributed at the 41st Annual Meeting of the Japanese Society of Pancreatic Surgery in Tokyo. We retrospectively analyzed the patient data including pathological diagnosis, postoperative outcomes, and evaluation methods. Results: Redo pancreatectomy was performed for secondary disease in 213 (1.4%) of a total 15,777 patients. Eighty-eight of these 213 patients had undergone initial resection of IPMN. The types of secondary tumors after IPMN resection significantly depended on those of the primary tumors. Through short-interval and long-term follow-up, most of the secondary tumors were detected within 1–4 years. Logistic regression analysis revealed that the initial pathological diagnosis of invasive IPMN was an independent predictor of secondary invasive tumors in the remnant pancreas. Conclusion: Primary invasive IPMN proved to be a significant predictor of secondary invasive IPMN. Both short-interval and long-term follow-up may help to determine the prognosis of patients after IPMN resection.
KW - Intraductal papillary mucinous neoplasm
KW - Redo pancreatectomy
KW - Secondary pancreatic remnant tumor
UR - http://www.scopus.com/inward/record.url?scp=85087835429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087835429&partnerID=8YFLogxK
U2 - 10.1007/s00595-020-02074-8
DO - 10.1007/s00595-020-02074-8
M3 - Article
C2 - 32661567
AN - SCOPUS:85087835429
VL - 50
SP - 1672
EP - 1680
JO - Surgery Today
JF - Surgery Today
SN - 0941-1291
IS - 12
ER -